Corporate | 3 November 2017 07:00

Evonik Industries AG: Evonik makes further progress in the third quarter

DGAP-News: Evonik Industries AG / Key word(s): Quarter Results

03.11.2017 / 07:00
The issuer is solely responsible for the content of this announcement.

Key Financial Data: Q3 2017

Evonik makes further progress in the third quarter

– Adjusted EBITDA rises 11 percent to EUR639 million

– Outlook for the full year specified: “in the upper half”

– Integration of Huber’s silica business is proceeding

Essen. Evonik increased adjusted EBITDA to EUR369 million in the third quarter, an increase of 11 percent compared with the third quarter of 2016. This was mainly due to better earnings in the Resource Efficiency and Performance Materials segments. A positive factor was the contribution made by the specialty additives business that Evonik acquired from the US company Air Products at the beginning of the year. Furthermore, the silica business acquired from J. M. Huber at the start of September made a contribution for the first time.

“Having completed the acquisition of Huber’s silica business, we reaped the benefit of both acquisitions for the first time,” said Executive Board Chairman Christian Kullmann. “The integration of both businesses is proceeding rapidly, and we have already realized initial synergies of around EUR10 million.”

Sales rose to EUR3.56 billion in the third quarter, adjusted net income increased to EUR275 million and adjusted earnings per share improved to EUR0.59. The company’s adjusted EBITDA margin was 18 percent, almost one percentage point higher than in the first six months. Free cash flow amounted to EUR485 million in the third quarter, about 70 percent above the prior-year level. Evonik has therefore generated a significantly positive free cash flow since the start of the year.

Outlook specified

Evonik confirmed that it will raise both sales and the operating profit in 2017. Following the positive performance in the third quarter, adjusted EBITDA is now expected to be in the upper half of the EUR2.2 billion to EUR2.4 billion range (2016: EUR2.165 billion).

Segment performance

Nutrition & Care: Sales increased 3 percent to EUR1.10 billion in the third quarter. This was attributable to the consolidation of the business acquired from Air Products and to higher sales volumes. Market conditions for feed additives have improved. Selling prices therefore stabilized in the third quarter but are still considerably lower than in the prior-year quarter. This was the main reason for the decline in adjusted EBITDA to EUR184 million in the
Nutrition & Care segment.

Resource Efficiency: Sales grew 22 percent to EUR1.36 billion in the third quarter. The silica business benefited from strong demand from the tire industry, and sales volumes of oil additives increased thanks to higher demand from the automotive, construction and transportation industries. Consolidation of the operations acquired from Air Products and Huber contributed 14 percentage points of the sales growth. Adjusted EBITDA rose to EUR312 million in the Resource Efficiency segment.

Performance Materials: Sales rose 15 percent to EUR919 million in the third quarter. High demand, especially from the coatings and automotive sectors, combined with continuing tight supply, led to higher selling prices. The adjusted EBITDA of the Performance Materials segment improved to EUR174 million.

Company information
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2016, the enterprise generated sales of around EUR12.7 billion and an operating profit (adjusted EBITDA) of about EUR2.165 billion.

Disclaimer
In so far as forecasts or expectations are expressed in this investor relations news or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

Contact:
Tim Lange
Head of Investor Relations
Phone +49 201 177-3150
tim.lange@evonik.com

Evonik Industries AG
Rellinghauser Straße 1-11
45128 Essen
Germany
Phone +49 201 177-01
Fax +49 201 177-3475
www.evonik.com

Supervisory Board
Dr. Werner Müller, Chairman
Executive Board
Christian Kullmann, Chairman
Dr. Harald Schwager, Deputy Chairman
Thomas Wessel
Ute Wolf

Registered Office is Essen
Register Court Essen Local Court
Commercial Registry B 19474

03.11.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Evonik Industries AG
	Rellinghauser Straße 1-11
	45128 Essen
	Germany
Phone:	+49 (0) 201 177-01
Fax:	+49 (0) 201 177-3475
E-mail:	investor-relations@evonik.com
Internet:	www.evonik.com
ISIN:	DE000EVNK013, XS0911405784
WKN:	EVNK01, A1TM7T
Indices:	MDAX
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Luxemburg

End of News DGAP News Service